ARYL AND ALCOHOL SULFOTRANSFERASES IN DRUG METABOLISM
药物代谢中的芳基和醇磺基转移酶
基本信息
- 批准号:2882324
- 负责人:
- 金额:$ 17.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-08-01 至 2000-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The long-term objective of this research is to better understand and more
reliably predict the roles that aryl sulfotransferase (AST) IV and alcohol
sulfotransferase STa play in the cytotoxic, mutagenic and/or carcinogenic
responses to drugs, carcinogens, and other xenobiotics. The accurate
prediction of metabolic reactions involving sulfotransferases is
particularly important for molecules that either possess or are converted
into metabolites containing benzylic alcohol, arylhydroxamic acid, and N-
hydroxy arylamine functional groups, since sulfation of these functional
groups is often the critical step in the formation of chemically reactive
metabolites that are capable of forming covalent bonds with cellular
macromolecules. Such Covalent bonding with critical cellular molecules is
the initial step leading to a variety of cytotoxic, immunologic,
mutagenic, and carcinogenic responses. The research proposed in this
application is based on the premise that quantitative analyses of the
catalytic specificities and mechanisms of sulfotransferases, as well as
the localizations and regulation of these enzymes within specific cells in
tissues such as the liver, are essential for accurately predicting the
potential for covalent alteration of cellular macromolecules within
individual cells.
Investigations on quantitative structure-activity relationships for AST IV
and STa will be focused on the hydrophobic and steric characteristics
required for binding and catalysis with these enzymes. These studies will
also provide generally applicable quantitative comparisons of the
stereoselectivity of the two sulfotransferases through use of a homologous
series of chiral substrates. A second specific aim of this project is to
identify and locate specific amino acid residues that contribute to the
substrate binding and catalytic activity of AST IV and STa. This
investigation both continues the successful use of ribonucleotide
dialdehyde affinity labeling reagents for elucidation of residues at the
binding site for 3'-phosphoadenosine 5'-phosphosulfate and employs new
approaches for the determination of residues at the sulfuryl acceptor
site. These new methods will utilize a homologous series of substrate-
analogs containing bromoacetamido groups as affinity labels for AST IV.
These affinity labels are designed to provide information on the relative
distances of specific amino acid residues from the site of sulfuryl
transfer on the enzyme. The third major component of this research is an
exploration of the basis for heterogeneity of AST IV and STa within
hepatocytes across the rat liver lobule by combining in situ hybridization
with immunohistochemical analyses. These investigations will provide
important new information on the relation of these two types of
sulfotransferases within liver.
这项研究的长期目标是更好地了解和更多
可靠地预测芳基磺基转移酶(AST)IV和酒精
磺基转移酶STa在细胞毒性、致突变和/或致癌中发挥作用
对药物、致癌物和其他外源性物质的反应。 准确
预测涉及磺基转移酶的代谢反应,
特别重要的是,对于那些拥有或被转化为
转化为含有苄醇、芳基异羟肟酸和N-
羟基芳基胺官能团,因为这些官能团硫酸化
基团通常是形成化学反应性的关键步骤,
能够与细胞形成共价键的代谢物
大分子这种与关键细胞分子的共价键合是
初始步骤导致多种细胞毒性的,免疫的,
致突变和致癌反应。这项研究提出,
应用的前提是,
磺基转移酶的催化特异性和机制,以及
这些酶在特定细胞内的定位和调节,
组织如肝脏,对于准确预测
潜在的共价改变细胞内的大分子
单个细胞。
AST IV的定量构效关系研究
和STa将集中在疏水和空间特性
与这些酶结合和催化所必需的。这些研究将
还提供了普遍适用的定量比较,
这两种磺基转移酶的立体选择性通过使用同源的
一系列手性底物。该项目的第二个具体目标是
鉴定和定位特定的氨基酸残基,
AST IV和STa的底物结合和催化活性。这
研究继续成功地使用核糖核苷酸
二醛亲和标记试剂,用于阐明
3 '-磷酸腺苷5'-磷酸硫酸盐的结合位点,并采用新的
测定硫酰受体上残留物的方法
绝佳的价钱 这些新方法将利用一系列同源的底物-
含有溴乙酰氨基基团的类似物作为AST IV的亲和标记。
这些亲和标记被设计为提供关于相对生物的信息。
特定氨基酸残基与硫酰基位点的距离
转移到酶上。这项研究的第三个主要组成部分是一个
探索AST IV和ST a异质性的基础,
原位杂交技术检测肝细胞跨肝小叶的跨膜表达
免疫组织化学分析。这些调查将提供
关于这两种类型的关系的重要新信息
肝脏内的磺基转移酶。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL W DUFFEL其他文献
MICHAEL W DUFFEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL W DUFFEL', 18)}}的其他基金
Project 3: PCBs and Cytosolic Phenol and Steroid Sulfotransferases
项目 3:多氯联苯和胞质苯酚和类固醇磺基转移酶
- 批准号:
8919612 - 财政年份:2006
- 资助金额:
$ 17.31万 - 项目类别:
Project 3: PCBs and Hydroxysteroid (Alcohol_ Sulfotransferases
项目 3:PCB 和羟基类固醇(酒精_磺基转移酶
- 批准号:
7106931 - 财政年份:2006
- 资助金额:
$ 17.31万 - 项目类别:
Project 3: PCBs and Cytosolic Phenol and Steroid Sulfotransferases
项目 3:多氯联苯和胞质苯酚和类固醇磺基转移酶
- 批准号:
9249563 - 财政年份:2006
- 资助金额:
$ 17.31万 - 项目类别:
ARYL AND ALCOHOL SULFOTRANSFERASES IN DRUG METABOLISM
药物代谢中的芳基和醇磺基转移酶
- 批准号:
6632936 - 财政年份:1984
- 资助金额:
$ 17.31万 - 项目类别:
ARYL SULFOTRANSFERASE IN DRUG AND XENOBIOTIC METABOLISM
药物和异生物代谢中的芳基磺基转移酶
- 批准号:
3176868 - 财政年份:1984
- 资助金额:
$ 17.31万 - 项目类别:
ARYL SULFOTRANSFERASE IN DRUG AND XENOBIOTIC METABOLISM
药物和异生物代谢中的芳基磺基转移酶
- 批准号:
3176873 - 财政年份:1984
- 资助金额:
$ 17.31万 - 项目类别:
ARYL SULFOTRANSFERASE IN DRUG AND XENOBIOTIC METABOLISM
药物和异生物代谢中的芳基磺基转移酶
- 批准号:
3176876 - 财政年份:1984
- 资助金额:
$ 17.31万 - 项目类别:
Aryl and Alcohol Sulfotransferases in Drug Metabolism
药物代谢中的芳基和醇磺基转移酶
- 批准号:
7874681 - 财政年份:1984
- 资助金额:
$ 17.31万 - 项目类别:
ARYL AND ALCOHOL SULFOTRANSFERASES IN DRUG METABOLISM
药物代谢中的芳基和醇磺基转移酶
- 批准号:
2089618 - 财政年份:1984
- 资助金额:
$ 17.31万 - 项目类别:
ARYL AND ALCOHOL SULFOTRANSFERASES IN DRUG METABOLISM
药物代谢中的芳基和醇磺基转移酶
- 批准号:
2089621 - 财政年份:1984
- 资助金额:
$ 17.31万 - 项目类别:
相似海外基金
Development of Affinity Labeling Approaches for Protein Identification
蛋白质鉴定亲和标记方法的开发
- 批准号:
554025-2020 - 财政年份:2020
- 资助金额:
$ 17.31万 - 项目类别:
University Undergraduate Student Research Awards
Design of a novel affinity labeling probe exhibiting fluorescence and luminescence
一种新型亲和标记探针的设计,具有荧光和发光功能
- 批准号:
16K17930 - 财政年份:2016
- 资助金额:
$ 17.31万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Affinity Labeling the Dopamine Transporter Active Site
多巴胺转运蛋白活性位点的亲和标记
- 批准号:
6731145 - 财政年份:2003
- 资助金额:
$ 17.31万 - 项目类别:
Affinity Labeling the Dopamine Transporter Active Site
多巴胺转运蛋白活性位点的亲和标记
- 批准号:
6868946 - 财政年份:2003
- 资助金额:
$ 17.31万 - 项目类别:
Affinity Labeling the Dopamine Transporter Active Site
多巴胺转运蛋白活性位点的亲和标记
- 批准号:
6579786 - 财政年份:2003
- 资助金额:
$ 17.31万 - 项目类别:
SGER: X-ray Crystallographic and Affinity Labeling Analysis of the Structure of Rat Epididymal N-Acetyl-B-D-hexosaminidase: Insight into the Catalytic Mechanism
SGER:大鼠附睾 N-乙酰基-B-D-氨基己糖苷酶结构的 X 射线晶体学和亲和标记分析:深入了解催化机制
- 批准号:
9804595 - 财政年份:1998
- 资助金额:
$ 17.31万 - 项目类别:
Standard Grant
Affinity Labeling of Nucleotide Sites in Proteins
蛋白质中核苷酸位点的亲和标记
- 批准号:
9728202 - 财政年份:1998
- 资助金额:
$ 17.31万 - 项目类别:
Continuing Grant
AFFINITY LABELING OF GLUTATHIONE S TRANSFERASES
谷胱甘肽 S 转移酶的亲和标记
- 批准号:
2654163 - 财政年份:1996
- 资助金额:
$ 17.31万 - 项目类别:
AFFINITY LABELING OF GLUTATHIONE S TRANSFERASES
谷胱甘肽 S 转移酶的亲和标记
- 批准号:
2871848 - 财政年份:1996
- 资助金额:
$ 17.31万 - 项目类别:
AFFINITY LABELING OF GLUTATHIONE S TRANSFERASES
谷胱甘肽 S 转移酶的亲和标记
- 批准号:
2109965 - 财政年份:1996
- 资助金额:
$ 17.31万 - 项目类别:














{{item.name}}会员




